← SynDRA
NADOLOL
SynDRA canonical compound SYN0012026 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | angina pectoris | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 ANTAGONIST
- ADRB2 ANTAGONIST
- ADRB3 ANTAGONIST
- ADRB1 MODULATOR
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympatholytics
ATC classes
- BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND THIAZIDES
Cross-references
Synonyms
- corgard
- anabet
- solgol
- NSC-758430
- SQ-11725
- Corgard
- Nadolol component of corzide
- Solgol
- Anabet
- Corgaretic
- Nadic
- Nadololum
- SQ11725
- Anabet (TN)
- Corgard (TN)
- Corzide (TN)
- Nadololum [INN-Latin]
- Solgol (TN)
- Alti-Nadolol (TN)
- Apo-Nadol (TN)
- Novo-Nadolol (TN)
- Nadolol (JP15/USP/INN)
- Nadolol [USAN:BAN:INN:JAN]
- (2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol
- (2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol
- (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
- 2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol
- 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol
- Corgard;Solgol
- SMR000304369
- rac-Nadolol
- Nadolol (Standard)
- Corzide (Salt/Mix)
- Prestwick3_000818
- Oprea1_423217
- BSPBio_000715
- MLS001333998
- MLS001333999
Look up NADOLOL in the interactive SynDRA portal →